Shionogi Set To Launch Japan's First Locally Developed Flu Antiviral
This article was originally published in PharmAsia News
Executive Summary
Shionogi of Japan announced its launch of the nation's first locally developed flu drug, Rapiacta (peramivir) an antiviral